FTFlorence K. L. Tangka

Florence K. L. Tangka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Florence K. L. Tangka has a total of 172 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Cost‐effectiveness of interventions to increase colorectal cancer screening among populations with low screening uptake

    by Florence K. L. Tangka, Sujha Subramanian, Sonja Hoover, Kate O’ROurke, Praveen Zirali, Alexander Preiss, Dara Schlueter, Stephanie Melillo, Sallyann Coleman King, Djenaba Joseph, et al.

    Background: The decrease in colorectal cancer (CRC) mortality over the past 2 decades is largely attributed to increased screening. This progress has not been evenly distributed across populations. Individuals who seek care at federally qualified health centers (FQHCs) have low CRC screening prevalence. This study aims to assess the effectiveness and cost of interventions to increase CRC screening at FQHCs, by using fecal immunochemical tests (FIT). Methods: The authors evaluated changes in FIT screening uptake in eight FQHCs that participated in the Colorectal Cancer Control Program (CRCCP) before and after the multicomponent evidence‐based interventions were implemented. Examples of interventions included patient reminders, provider assessment and feedback, and patient navigation. They collected the labor and nonlabor cost of implementing the interventions. Furthermore, they used a validated microsimulation model to assess the long‐term cost‐effectiveness of the interventions. Results: All eight FQHCs showed increases in CRC screening following the implementation of the multicomponent interventions, with an average increase of 14.4 percentage points (range, 4.9–26.7) and an average intervention cost of $14.40 per person (range, $5.76–$34.70). In five of the eight FQHCs, the interventions resulted in cost savings when public payer costs were considered. In the remaining three FQHCs, the cost per life years saved ranged from $14,898 to $54,111. Conclusions: Multicomponent interventions to increase the use of FIT kits represent an effective and efficient strategy for increasing CRC screening uptake in FQHCs.

  • Outcomes and cost of patient navigation in increasing colorectal cancer screening in a safety net hospital-based health center

    by Florence K. L. Tangka, Sonja Hoover, Mark Krudy, Marjorie Locke, Jennifer Tran, Senkuta Riverson, Samantha Wasala, Tariku Mekonnen, April Vance, Sujha Subramanian

    Purpose To assess the screening outcomes and cost of patient navigation (PN) to improve colorectal cancer (CRC) screening uptake of stool-based tests and colonoscopies in a safety net setting. Methods We conducted a quantitative assessment of a PN program at MedStar, a nonprofit hospital system based in the Washington, DC area. We collected and analyzed data for the 2023 calendar year on sociodemographic characteristics of patients, screening test completion, barriers to screening, and the labor and non-labor costs of the PN program. The main outcome measures for this study included the number of patients navigated, overall screening uptake and follow-up procedure completion rates. We also calculated the cost of the PN program, the average cost per person navigated, and the cost per patient who completed a screening or follow-up procedure. Results MedStar’s PN program navigated 1,287 patients, of whom 77.5% were reached and 43.5% completed screening or follow-up procedures. Another 20.9% of persons navigated were still in the process of completing screening or follow-up colonoscopies (e.g., awaiting appointments). The most common barriers reported were challenges related to bowel preparation (25.3%) and comorbidities (13.7%). The average cost per person to deliver navigation was $209.83, while the average cost per patient successfully navigated to complete procedures was $482.23. Conclusion PN is effective in increasing CRC screening and follow-up and this improvement can be achieved at a reasonable cost in safety net settings. Future research should investigate approaches to reach all patients referred for navigation and optimal approaches to address patient barriers.

  • Cost of colorectal cancer screening in two tribal health organizations in Alaska

    by Florence K. L. Tangka, Sonja Hoover, Mark Krudy, Cara Brown, Susan Tessier, Willyam Hodson, Diana Redwood, Lauren Smayda, Donald Haverkamp, Michelle Poole, et al.

    Purpose We conducted a comprehensive assessment of the resources required to undergo colorectal cancer (CRC) screening in two Alaska Native tribal health organizations. Methods We evaluated the cost of CRC screening at Maniilaq Association and Bristol Bay Area Health Corporation, and the communities they serve. We developed a tailored data collection tool to gather data from health clinics. We calculated the cost of screening tests and patient costs. We also conducted interviews with clinic representatives to identify contextual factors that can affect cost estimates. Results The cost of fecal immunochemical tests and fecal occult blood tests ranged from $53 to $76. The cost of the colonoscopy procedure ranged from $2,600 to $4,066. Travel costs, including per diem, ranged from $1,561 to $1,740. The cost of missed work was estimated to be $1,008 for patients and medical escorts for both communities. The total cost of receiving a colonoscopy, including procedural costs, travel costs, and the cost of missed work, ranged from $5,348 to $6,635. Conclusion We found the cost of the screening tests, travel costs and the cost of missed work to undergo CRC screening were higher in Alaska than national averages. Program planning could benefit from accounting for the costs and additional resources needed in Alaska due to the geography of the state and the location of providers and facilities.

  • A multimodal analysis of resource allocation across U.S. cancer registries

    by Maggie Cole-Beebe, Florence K.L. Tangka, Jenny Beizer, Amarilys Bernacet, Stephen Brown, Paran Pordell, Reda Wilson, Sandy Jones, Sujha Subramanian


  • Open Access

    Improving the efficiency of integrated cancer screening delivery across multiple cancers: case studies from Idaho, Rhode Island, and Nebraska

    by Florence K. L. Tangka, Sujha Subramanian, Sonja Hoover, Charlene Cariou, Becky Creighton, Libby Hobbs, Amanda Marzano, Andrea Marcotte, Deirdre Denning Norton, Patricia Kelly-Flis, et al.

    Background: Three current and former awardees of the Centers for Disease Control and Prevention’s Colorectal Cancer Control Program launched integrated cancer screening strategies to better coordinate multiple cancer screenings (e.g., breast, cervical, colorectal). By integrating the strategies, efficiencies of administration and provision of screenings can be increased and costs can be reduced. This paper shares findings from these strategies and describes their effects. Methods: The Idaho Department of Health and Welfare developed a Baseline Assessment Checklist for six health systems to assess the current state of policies regarding cancer screening. We analyzed the checklist and reported the percentage of checklist components completed. In Rhode Island, we collaborated with a nurse-patient navigator, who promoted cancer screening, to collect details on patient navigation activities and program costs. We then described the program and reported total costs and cost per activity. In Nebraska, we described the experience of the state in administering an integrated contracts payment model across colorectal, breast, and cervical cancer screening and reported cost per person screened. Across all awardees, we interviewed key stakeholders. Results: In Idaho, results from the checklist offered guidance on areas for enhancement before integrated cancer screening strategies, but identified challenges, including lack of capacity, limited staff availability, and staff turnover. In Rhode Island, 76.1% of 1023 patient navigation activities were for colorectal cancer screening only, with a much smaller proportion devoted to breast and cervical cancer screening. Although the patient navigator found the discussions around multiple cancer screening efficient, patients were not always willing to discuss all cancer screenings. Nebraska changed its payment system from fee-for-service to fixed cost subawards with its local health departments, which integrated cancer screening funding. Screening uptake improved for breast and cervical cancer but was mixed for colorectal cancer screening. Conclusions: The results from the case studies show that there are barriers and facilitators to integrating approaches to increasing cancer screening among primary care facilities. However, more research could further elucidate the viability and practicality of integrated cancer screening programs.


  • Open Access

    Integrated approaches to delivering cancer screenings to address disparities: lessons learned from the evaluation of CDC’s Colorectal Cancer Control Program

    by Sujha Subramanian, Florence K. L. Tangka, Amy DeGroff, Lisa C. Richardson

    Background: The Centers for Disease Control and Prevention launched the Colorectal Cancer Control Program to increase colorectal cancer screening among groups with low screening uptake. This engagement has enabled the health systems participating in the program to enhance infrastructure, systems, and process to implement interventions for colorectal cancer screening. These improvements have enabled other health promotion innovations such as the delivery of integrated interventions and supporting activities (referred to as integrated approaches) for multiple cancers. Using implementation science frameworks, the program evaluation team has examined these integrated approaches to capture the experiences of the awardees, health systems, and clinics. Methods and results: The findings from this comprehensive evaluation are presented in a series of 3 manuscripts. The first manuscript provides a conceptual framework for integrated approaches for cancer screening to support comprehensive evaluations and offers recommendations for future research. The second manuscript presents findings on key factors that support readiness for implementing integrated approaches based on qualitative interviews guided by implementation science constructs. The final manuscript reports on the challenges and benefits of integrated approaches to increase cancer screening in primary care facilities based on lessons learned from three real-world implementation case studies. Conclusion: Integrated models for implementing cancer screening could offer cost-effective approaches to reduce healthcare disparities. Additional implementation science-based systematic evaluations are needed to ensure integrated approaches are optimized, and cost-efficient models are scaled up.


  • Open Access

    Integrated interventions and supporting activities to increase uptake of multiple cancer screenings: conceptual framework, determinants of implementation success, measurement challenges, and research priorities

    by Sujha Subramanian, Florence K. L. Tangka, Sonja Hoover, Amy DeGroff

    Background: Screening for colorectal, breast, and cervical cancer has been shown to reduce mortality; however, not all men and women are screened in the USA. Further, there are disparities in screening uptake by people from racial and ethnic minority groups, people with low income, people who lack health insurance, and those who lack access to care. The Centers for Disease Control and Prevention funds two programs—the Colorectal Cancer Control Program and the National Breast and Cervical Cancer Early Detection Program—to help increase cancer screenings among groups that have been economically and socially marginalized. The goal of this manuscript is to describe how programs and their partners integrate evidence-based interventions (e.g., patient reminders) and supporting activities (e.g., practice facilitation to optimize electronic medical records) across colorectal, breast, and cervical cancer screenings, and we suggest research areas based on implementation science. Methods: We conducted an exploratory assessment using qualitative and quantitative data to describe implementation of integrated interventions and supporting activities for cancer screening. We conducted 10 site visits and follow-up telephone interviews with health systems and their partners to inform the integration processes. We developed a conceptual model to describe the integration processes and reviewed screening recommendations of the United States Preventive Services Task Force to illustrate challenges in integration. To identify factors important in program implementation, we asked program implementers to rank domains and constructs of the Consolidated Framework for Implementation Research. Results: Health systems integrated interventions for all screenings across single and multiple levels. Although potentially efficient, there were challenges due to differing eligibility of screenings by age, gender, frequency, and location of services. Program implementers ranked complexity, cost, implementation climate, and engagement of appropriate staff in implementation among the most important factors to success. Conclusion: Integrating interventions and supporting activities to increase uptake of cancer screenings could be an effective and efficient approach, but we currently do not have the evidence to recommend widescale adoption. Detailed multilevel measures related to process, screening, and implementation outcomes, and cost are required to evaluate integrated programs. Systematic studies can help to ascertain the benefits of integrating interventions and supporting activities for multiple cancer screenings, and we suggest research areas that might address current gaps in the literature.


  • Factors Affecting the Adoption of Electronic Data Reporting and Outcomes Among Selected Central Cancer Registries of the National Program of Cancer Registries

    by Florence K. L. Tangka, Patrick Edwards, Paran Pordell, Reda Wilson, Wendy Blumenthal, Sandy F. Jones, Madeleine Jones, Jenny Beizer, Amarilys Bernacet, Maggie Cole-Beebe, et al.

    PURPOSE: The CDC's National Program of Cancer Registries has expanded the use of electronic reporting to collect more timely information on newly diagnosed cancers. The adoption, implementation, and use of electronic reporting vary significantly among central cancer registries. We identify factors affecting the adoption of electronic reporting among these registries. METHODS: Directors and data managers of nine National Program of Cancer Registries took part in separate 1-hour telephone interviews in early 2019. Directors were asked about their registry's key data quality goals; staffing, resources, and tools used to aid processes; their definition and self-perception of electronic reporting adoption; key helpers and challenges; and cost and sustainability implications for adoption of electronic reporting. Data managers were asked about specific data collection processes, software applications, electronic reporting adoption and self-perception, information technology infrastructure, and helpers and challenges to data collection and processing, data quality, and sustainability of approach. RESULTS: Larger registries identified organizational capacity and technical expertise as key aides. Other help for implementing electronic reporting processes came from partnerships, funding availability, management support, legislation, and access to an interstate data exchange. Common challenges among lower adopters included lack of capacity at both registry and data source levels, insufficient staffing, and a lack of information technology or technical support. Other challenges consisted of automation and interoperability of software, volume of cases received, state political environment, and quality of data received. CONCLUSION: Feedback from the formative evaluation yielded several useful solutions that can guide implementation of electronic reporting and help refine the technical assistance provided to registries. Our findings may help guide future process and economic evaluations of electronic reporting and identify best practices to strengthen registry operations.


  • Geographic Disparities in Late-Stage Breast Cancer Diagnosis Rates and Their Persistence Over Time

    by Lee R. Mobley, Florence K.L. Tangka, Zahava Berkowitz, Jacqueline Miller, Ingrid J. Hall, Manxia Wu, Susan A. Sabatino

    Background: Other than skin cancer, breast cancer is the most common cancer in the United States. Lower uptake of mammography screening is associated with higher rates of late-stage breast cancers. This study aims to show geographic patterns in the United States, where rates of late-stage breast cancer are high and persistent over time, and examines factors associated with these patterns. Materials and Methods: We examined all primary breast cancers diagnosed among all counties in 43 U.S. states with available data. We used spatial cluster analysis to identify hot spots (i.e., spatial clusters with above average late-stage diagnosis rates among counties). Demographic and socioeconomic characteristics were compared between persistent hot spots and those counties that were never hot spots. Results: Of the 2,599 counties examined in 43 states, 219 were identified as persistent hot spots. Counties with persistent hot spots (compared with counties that were never hot spots) were located in more deprived areas with worse housing characteristics, lower socioeconomic status, lower levels of health insurance, worse access to mammography, more isolated American Indian/Alaska Native, Black, or Hispanic neighborhoods, and larger income disparity. In addition, persistent hot spots were significantly more likely to be observed among poor, rural, African American, or Hispanic communities, but not among poor, rural, White communities. This analysis includes a broader range of socioeconomic conditions than those included in previous literature. Conclusion: We found geographic disparities in late-stage breast cancer diagnosis rates, with some communities experiencing persistent disparities over time. Our findings can guide public health efforts aimed at reducing disparities in stage of diagnosis for breast cancer.


  • Open Access

    The Effectiveness and Cost to Improve Colorectal Cancer Screening in a Federally Qualified Homeless Clinic in Eastern Kentucky

    by Vicky Hardin, Florence K. L. Tangka, Teri Wood, Brian Boisseau, Sonja Hoover, Amy DeGroff, Jennifer Boehm, Sujha Subramanian

    The objective of this study was to analyze the effectiveness and cost of patient incentives, together with patient navigation and patient reminders, to increase fecal immunochemical test (FIT) kit return rates and colorectal cancer screening uptake in one federally qualified health center (FQHC) in Appalachia. This FQHC is a designated homeless clinic, as 79.7% of its patient population are homeless. We collected process, outcome, and cost data from the FQHC for two time periods: usual care (September 2016–August 2017) and implementation (September 2017–September 2018). We reported the FIT kit return rate, the increase in return rate, and the additional number of individual screens. We also calculated the incremental cost per additional screen. The patient incentive program, with patient navigation and patient reminders, increased the number of FIT kits returned from the usual care period to the implementation period. The return rate increased by 25.9 percentage points (from 21.7% to 47.6%) with an additional 91 people screened at an incremental cost of $134.61 per screen. A patient incentive program, together with the assistance of patient navigators and supplemented with patient reminders, can help improve CRC screening uptake among vulnerable and homeless populations.